학술논문

Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia June 2023 23(6):446-455
Subject
Language
ISSN
2152-2650